Avastin 25 mg/ml concentrate for solution for infusion.
Concentrate for solution for infusion.
Clear to slightly opalescent, colourless to pale brown liquid.
Each ml of concentrate contains 25 mg of bevacizumab*.
Each 4 ml vial contains 100 mg of bevacizumab.
Each 16 ml vial contains 400 mg of bevacizumab.
For dilution and other handling recommendations, see section 6.6.
* Bevacizumab is a recombinant humanised monoclonal antibody produced by DNA technology in Chinese Hamster Ovary cells.
For the full list of excipients, see section 6.1.
Water for injections
Pack of 1 vial.
Roche Registration GmbH, Emil-Barell-Strasse 1, 79639, Grenzach-Wyhlen, Germany
EU/1/04/300/001 – 100 mg/4 ml vial
EU/1/04/300/002 – 400 mg/16 ml vial
Date of first authorisation: 12 January 2005
Date of latest renewal: 14 January 2015